显示标签为“leukemia”的博文。显示所有博文
显示标签为“leukemia”的博文。显示所有博文

2016年5月25日星期三

Understanding more about the molecular pathogenesis of leukemia

Scientists conducted genome research on B acute lymphoblastic leukemia (B-ALL) and gained significant progress, full analysing molecular pathogenesis of the disease and providing a new model for medical precision. Related study was recently published in the journal E biomedicine.

B-ALL is a common type of acute leukemia and more common in children. It accounts 20% of adult acute leukemia. Long-term survival of B-ALL among Chinese children reaches about 70%, but there are still 20% to 30% of treatment failure, and adult long-term survival rate is only about 20%.

The United Study Group first used international application of the full set of exons, whole genome and whole transcriptome sequencing to conduct panoramic analysis of the genome on 92 adults and 111 children with B-ALL. This study not only confirmed the known major genetic abnormalities of the disease but also found 105 reproducible gene sequence mutations and 29 fusion gene which were not previously reported.

Studies have shown that fusion genes associated with MEF2D and ZNF384 can block the differentiation of early B lymphocytes, and ZNF384 fusion gene can also induce acute leukemia in a mouse model. The study also found that compared to the condition of children that they have a higher rate of positive fusion gene and poor prognosis, the molecular markers of good prognosis is obviously less, and the number of mutations in the gene sequence is significantly more.

The study reveals the pathogenesis of B-ALL, improving existing molecular diagnostic and prognostic classification system and prompting the intervention strategies of regulatory pathway for the B-ALL of abnormity of each group. One of the authors, Chinese Academy of Engineering academician Chen Saijuan said that the research result show direct application conversion prospects. Or the B-ALL precise classification model can be promoted to other leukemia and solid tumors, promoting the development of Chinese and international translational medicine and precision medicine.

Read more: http://www.cusabio.com/ELISA-Kit/Bovine-Japanese-Encephalitis-AntibodyIgGELISA-Kit-1042169.html

2016年3月29日星期二

Researchers from Chinese elite school uncovers the roles of miRNA in leukemia

Leukemia is a malignant tumor in hematopoietic system, commonly known as "blood cancer". In this disease, certain types of leukemia cells show neoplastic hyperplasia in bone marrow or other hematopoietic tissues, they can infiltrate the body's different organs and tissues, resulting in dysfunction of each organ and producing signs and symptoms. The leukemia can be divided into acute and chronic categories according to the cell differentiation.

In recent years, people gradually realized that the extracellular microenvironment vesicles (MV) play an important role in the development and recurrence of cancer. Researchers at Chinese Huazhong University of Science and Technology published an article in the journal Cancer Research that the miRNA in micro vesicles will push leukemic transformation of hematopoietic cells. The corresponding author of the article is Professor Guoan Yuan at School of Life Science and Technology of Huazhong University of Science and Technology.

Studies have shown that chronic myeloid leukemia (CML) K562 cell micro-vesicles, to make into leukemia-like cells in normal hematopoietic stem cells. The researchers found that in the early stages of the micro-vesicles hematopoietic stem cell malignant transformation initiated a number of anti-cancer miRNA pathway and defense, but later involved in cell cycle, DNA repair and energy metabolism and carcinogenicity of miRNA genes up-regulated.

Further studies have shown that high levels of expression in micro vesicles miR-146b-5p regulate cancer-related genes, and thereby promote the transformation of hematopoietic cells. This miRNA inhibitor NUMB main function will increase the level of ROS cells, enhancing genomic instability by silencing tumor.

Genes are the blueprint for a protein, while miRNA helps cells decide whether to manufacture these proteins according to the blueprint. miRNA is long non-coding RNA which is 22nt, bearing a crucial function in the regulation of important processes of embryonic development, cell differentiation and organ generation and the like. These short RNAs largely exist in natural cells. They can be paired with the target gene mRNA and hinder its translation and regulate its expression of target genes in the post-transcriptional level.

Read more: http://www.cusabio.com/ELISA-Kit/Human-papillomavirus-type-18-HPV18-antibody-IgM-ELISA-kit-1042057.html